View in EDS HTML Full Text PDF Full Text

Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia.

Saved in:
Bibliographic Details
Title: Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia.
Authors: Hasan, Marah Alsayed1 (AUTHOR), Mukaddam, Mona Al1 (AUTHOR)
Source: JCEM Case Reports. Jun2026, Vol. 4 Issue 6, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:27551520
DOI:10.1210/jcemcr/luag086